Literature DB >> 14581549

Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.

Prasith Baccam1, Robert J Thompson, Yuxing Li, Wendy O Sparks, Michael Belshan, Karin S Dorman, Yvonne Wannemuehler, J Lindsay Oaks, James L Cornette, Susan Carpenter.   

Abstract

Lentiviruses exist in vivo as a population of related, nonidentical genotypes, commonly referred to as quasispecies. The quasispecies structure is characteristic of complex adaptive systems and contributes to the high rate of evolution in lentiviruses that confounds efforts to develop effective vaccines and antiviral therapies. Here, we describe analyses of genetic data from longitudinal studies of genetic variation in a lentivirus regulatory protein, Rev, over the course of disease in ponies experimentally infected with equine infectious anemia virus. As observed with other lentivirus data, the Rev variants exhibited a quasispecies character. Phylogenetic and partition analyses suggested that the Rev quasispecies comprised two distinct subpopulations that coexisted during infection. One subpopulation appeared to accumulate changes in a linear, time-dependent manner, while the other evolved radially from a common variant. Over time, the two subpopulations cycled in predominance coincident with changes in the disease state, suggesting that the two groups differed in selective advantage. Transient expression assays indicated the two populations differed significantly in Rev nuclear export activity. Chimeric proviral clones containing Rev genotypes representative of each population differed in rate and overall level of virus replication in vitro. The coexistence of genetically distinct viral subpopulations that differ in phenotype provides great adaptability to environmental changes within the infected host. A quasispecies model with multiple subpopulations may provide additional insight into the nature of lentivirus reservoirs and the evolution of antigenic and drug-resistant variants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581549      PMCID: PMC254257          DOI: 10.1128/jvi.77.22.12122-12131.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Independent evolution of HIV type 1 in different brain regions.

Authors:  P Shapshak; D M Segal; K A Crandall; R K Fujimura; B T Zhang; K Q Xin; K Okuda; C K Petito; C Eisdorfer; K Goodkin
Journal:  AIDS Res Hum Retroviruses       Date:  1999-06-10       Impact factor: 2.205

2.  Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Authors:  S A Hammond; F Li; B M McKeon; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.

Authors:  M Belshan; P Baccam; J L Oaks; B A Sponseller; S C Murphy; J Cornette; S Carpenter
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

4.  Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

Authors:  T W Chun; R T Davey; M Ostrowski; J Shawn Justement; D Engel; J I Mullins; A S Fauci
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

5.  Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.

Authors:  G M Ortiz; M Wellons; J Brancato; H T Vo; R L Zinn; D E Clarkson; K Van Loon; S Bonhoeffer; G D Miralles; D Montefiori; J A Bartlett; D F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

6.  Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.

Authors:  M Belshan; G S Park; P Bilodeau; C M Stoltzfus; S Carpenter
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.

Authors:  R T Davey; N Bhat; C Yoder; T W Chun; J A Metcalf; R Dewar; V Natarajan; R A Lempicki; J W Adelsberger; K D Miller; J A Kovacs; M A Polis; R E Walker; J Falloon; H Masur; D Gee; M Baseler; D S Dimitrov; A S Fauci; H C Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

8.  Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

Authors:  C Leroux; J K Craigo; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  PAQ: Partition Analysis of Quasispecies.

Authors:  P Baccam; R J Thompson; O Fedrigo; S Carpenter; J L Cornette
Journal:  Bioinformatics       Date:  2001-01       Impact factor: 6.937

10.  Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.

Authors:  R P van Rij; H Blaak; J A Visser; M Brouwer; R Rientsma; S Broersen; A M de Roda Husman; H Schuitemaker
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

View more
  14 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Rev-RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates.

Authors:  Patrick E Jackson; Denis M Tebit; David Rekosh; Marie-Louise Hammarskjold
Journal:  AIDS Res Hum Retroviruses       Date:  2016-06-03       Impact factor: 2.205

3.  Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment.

Authors:  Elena Moreno; Isabel Gallego; Josep Gregori; Adriana Lucía-Sanz; María Eugenia Soria; Victoria Castro; Nathan M Beach; Susanna Manrubia; Josep Quer; Juan Ignacio Esteban; Charles M Rice; Jordi Gómez; Pablo Gastaminza; Esteban Domingo; Celia Perales
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

4.  Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.

Authors:  Jae-Hyung Lee; Sean C Murphy; Michael Belshan; Wendy O Sparks; Yvonne Wannemuehler; Sijun Liu; Thomas J Hope; Drena Dobbs; Susan Carpenter
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.

Authors:  Wendy Maury; Robert J Thompson; Quentin Jones; Sarahann Bradley; Tara Denke; Prasith Baccam; Matthew Smazik; J Lindsay Oaks
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.

Authors:  Chringma Sherpa; Patrick E H Jackson; Laurie R Gray; Kathryn Anastos; Stuart F J Le Grice; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

7.  Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity.

Authors:  Wendy O Sparks; Karin S Dorman; Sijun Liu; Susan Carpenter
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891

8.  Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization.

Authors:  Emily A Sloan; Mary F Kearney; Laurie R Gray; Kathryn Anastos; Eric S Daar; Joseph Margolick; Frank Maldarelli; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

9.  Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.

Authors:  Patrick E H Jackson; Godfrey Dzhivhuho; David Rekosh; Marie-Louise Hammarskjold
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

10.  Structural model of the Rev regulatory protein from equine infectious anemia virus.

Authors:  Yungok Ihm; Wendy O Sparks; Jae-Hyung Lee; Haibo Cao; Susan Carpenter; Cai-Zhuang Wang; Kai-Ming Ho; Drena Dobbs
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.